Epworth Hospital

Richmond, Victoria 3121

3 studies enrolling now · 8 studies all time

What they study most

Breast Adenocarcinoma, Chronic Kidney Failure, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Restenosis, Hormone Receptor Positive, Lymphoma, Multiple Myeloma, Myocardial Ischemia, Non-Small Cell Lung Cancer, Stage IA Breast Cancer AJCC v7

Studies at this site

• A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma — Recruiting now
• Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) — Recruiting now
• A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) — Recruiting now
• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC — Completed
• SPIRIT PRIME Clinical Trial — Completed
• TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions — Completed
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate — Stopped early